Hermes Florez to Cardiovascular Diseases
This is a "connection" page, showing publications Hermes Florez has written about Cardiovascular Diseases.
Connection Strength
2.776
-
Differences in complications, cardiovascular risk factor, and diabetes management among participants enrolled at veterans affairs (VA) and non-VA medical centers in the glycemia reduction approaches in diabetes: A comparative effectiveness study (GRADE). Diabetes Res Clin Pract. 2022 Feb; 184:109188.
Score: 0.457
-
Weight loss and physical activity for disease prevention in obese older adults: an important role for lifestyle management. Curr Diab Rep. 2014 Oct; 14(10):539.
Score: 0.277
-
Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance. Diabetes Obes Metab. 2014 Apr; 16(4):326-33.
Score: 0.260
-
Beyond the obesity paradox in diabetes: fitness, fatness, and mortality. JAMA. 2012 Aug 08; 308(6):619-20.
Score: 0.239
-
Multi-trait association studies discover pleiotropic loci between Alzheimer's disease and cardiometabolic traits. Alzheimers Res Ther. 2021 02 04; 13(1):34.
Score: 0.215
-
Intensive Glucose Control in Patients with Type 2 Diabetes - 15-Year Follow-up. N Engl J Med. 2019 Jun 06; 380(23):2215-2224.
Score: 0.192
-
Black Hispanics have a worse cardiovascular risk profile than mixed Hispanics in Venezuela. Invest Clin. 2007 Mar; 48(1):45-55.
Score: 0.164
-
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015 Jun 04; 372(23):2197-206.
Score: 0.145
-
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014 Aug; 2(8):634-47.
Score: 0.135
-
Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes. Nat Commun. 2021 05 10; 12(1):2579.
Score: 0.109
-
Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors. Diabetes. 2020 01; 69(1):112-120.
Score: 0.098
-
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019 07 13; 394(10193):121-130.
Score: 0.096
-
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009 Jan 08; 360(2):129-39.
Score: 0.093
-
Hyperglycemia and dyslipidemia of Isabela, Gal?pagos, Ecuador: A pilot study of cardiovascular risk factors in an Isolated Island community. Diabetes Res Clin Pract. 2017 Aug; 130:108-112.
Score: 0.083
-
Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial. Diabetes Obes Metab. 2015 Oct; 17(10):949-55.
Score: 0.073
-
Gender Differences in Demographic and Health Characteristics of the Million Veteran Program Cohort. Womens Health Issues. 2019 06 25; 29 Suppl 1:S56-S66.
Score: 0.048
-
The Avandia debacle: methodology and practical importance of the findings. South Med J. 2007 Nov; 100(11):1062-3.
Score: 0.043
-
Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population. Atherosclerosis. 2006 Sep; 188(1):134-41.
Score: 0.037
-
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009 Nov 14; 374(9702):1677-86.
Score: 0.012